相关实验视频

Updated: Jan 9, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

MiR-200b-3p通过向DDIT4参与结直肠癌的进展

Zhimin Liu¹, Yiping Li², Shangkui Xie³

¹Department of General Surgery (anal surgery), the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. liuzhm3@mail.sysu.edu.cn.

Cellular and molecular biology (Noisy-le-Grand, France)

|December 6, 2025

概括

DNA损伤诱导的转录4 (DDIT4) 促进结直肠癌 (CRC) 的进展. 微RNA-200b-3p (miR-200b-3p) 调节DDIT4,这表明miR-200b-3p/DDIT4轴是CRC的潜在治疗标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

结肠直肠癌 (CRC) 是一个重要的健康问题,具有复杂的分子基础.
确定新的治疗点对于改善CRC治疗结果至关重要.

研究的目的:

研究CRC中microRNA-200b-3p (miR-200b-3p) 和DNA损伤诱导的转录4 (DDIT4) 之间的功能关系.
评估miR-200b-3p/DDIT4轴作为CRC治疗策略的潜力.

主要方法:

使用生物信息数据库 (GEPIA,HPA,ENCORI) 对DDIT4表达的泛癌分析.
在CRC临床样本上进行免疫组织化学检测,以评估DDIT4蛋白水平.
在DDIT4淘汰后,在CRC细胞中进行功能性测试 (细胞增殖,迁移,入侵).
路西法酶记者测定证实了miR-200b-3p和DDIT4mRNA之间的直接相互作用.

主要成果:

与其他癌症相比,DDIT4在CRC中显著上调,与预后不佳相关.
DDIT4敲除抑制了CRC细胞的增殖,迁移和入侵.
miR-200b-3p直接针对DDIT4,其低表达与不利的CRC结果有关.
过度表达DDIT4抵消了CRC细胞中miR-200b-3p的瘤抑制作用.

结论:

在CRC的进展中,DDIT4起着促瘤作用.
miR-200b-3p/DDIT4监管轴是CRC发展的一个关键因素.
准miR-200b-3p/DDIT4通路为结直肠癌提供了一个有前途的治疗途径.

更多相关视频

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...